Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Partner Grants

American Thoracic Society

ATS/ALA Commemorative 120th Anniversary Joint Research Award

One grant available
$60,000 per year for two years

Target Audience: Early-stage investigators

This grant will fund basic, translational or clinical research that has a high likelihood of advancing the understanding of lung disease.

ALA/ATS/CHEST Respiratory Health Equity Research Award

One grant available
$100,000 per year for two years

Target Audience: Early-stage investigators who are addressing topics on improving clinical outcomes in preventing and/or treating lung disease in groups disproportionately impacted.

The focus of this grant is clinical research that addresses topics on improving clinical outcomes in preventing and/or treating lung disease that disproportionately affects underrepresented minority (URM) patient groups. URM patient groups includes patients from lower-middle- and low-income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and Native Hawaiians), Pacific Islanders, and mainland Puerto Ricans.

ATS/Alpha-1 Foundation Young Investigator Grant in Alpha-1 Antitrypsin Deficiency

One grant available
$50,000 for one year

Target Audience: Early-career investigators interested in Alpha-1 Antitrypsin Deficiency research.

The objective of this grant is to provide support for early-career investigators who are starting their research careers and intend to pursue a career in Alpha-1 Antitrypsin Deficiency research.

ATS/Chiesi USA, Inc. Research Grant in Obstructive Lung Disease

One grant available
$50,000 for one year

Target Audience: Early-stage investigators interested in obstructive lung disease research.

This grant will support research that has a high likelihood of advancing the understanding of obstructive lung disease through basic, translational or clinical research.

ATS/Fisher & Paykel Healthcare Research Grant in Nasal High Flow

One grant available
$50,000 for one year

Target Audience: Early-stage investigators interested in research on respiratory support with nasal high flow therapy in patients managed in the emergency department, intensive care unit, or ward.

The focus of this research grant is proposals on respiratory support with nasal high flow therapy in adult patients. Patients must be in the hospital care during their involvement in the project.

ATS/Margaret W. Leigh/PCD Foundation Early Career Investigator Award

One grant available
$60,000 for one year

Target Audience: Early-stage investigators interested in primary ciliary dyskinesia research.

The PCD Foundation Margaret W. Leigh Early Career Investigator Award supports emerging PhD and physician scientists who are actively involved in research in primary ciliary dyskinesia to allow them to develop into independent biomedical investigators. The proposed research must be relevant to the mission of the PCD Foundation, improving the health and well-being of patients with primary ciliary dyskinesia.

ATS/Foundation for Sarcoidosis Research Grant

One grant available
$50,000 per year for two years

Target Audience: Early-stage investigators interested in research that is relevant to sarcoidosis.

This research grant focuses on proposals that advance research in sarcoidosis. Applicants may request up to $50,000 per year for two years. Grant funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution.

ATS Early Career Investigator Award in Pulmonary Vascular Disease

Four grants available
$100,000 for one year

Target Audience: Early-stage investigators conducting research on the basic mechanisms and/or vascular biology of pulmonary vascular disease. Applicants may be a junior faculty member up to and including the rank of assistant professor, a postdoctoral scholar, a doctoral candidate, or a fellow.

Note that the definition for early-stage investigator for this award differs from that of other ATS awards. View complete eligibility requirements.

This grant supports basic, translational, and clinical research aimed at understanding the pathways and pathophysiology of pulmonary vascular disease, with the goal of improving treatment for patients with pulmonary hypertension.

Deadline: Dec. 16, 2024

Specialties

Medical

Medical - Clinical Science

Medical - Basic Science

Medical - Translational

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: American Thoracic Society

Address: 25 Broadway ;New York, NY 10004; United States of America;

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity